Linked Data API

Show Search Form

Search Results

1329368
registered interest false more like this
date less than 2021-06-04more like thismore than 2021-06-04
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Coronavirus: Vaccination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the merits of prioritising clinically extremely vulnerable children for a covid-19 vaccine if licensed for use in children. more like this
tabling member constituency Dulwich and West Norwood more like this
tabling member printed
Helen Hayes more like this
uin 10529 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2021-06-10more like thismore than 2021-06-10
answer text <p>The Pfizer/BioNTech vaccine has now been authorised by the Medicines and Healthcare products Regulatory Agency for use in children aged 12 to 15 years old in the United Kingdom. The Government will now be guided by the advice of experts, including the Joint Committee on Vaccination and Immunisation (JCVI), on any potential routine deployment of COVID-19 vaccination in children.</p> more like this
answering member constituency Stratford-on-Avon remove filter
answering member printed Nadhim Zahawi more like this
question first answered
less than 2021-06-10T15:43:27.053Zmore like thismore than 2021-06-10T15:43:27.053Z
answering member
4113
label Biography information for Nadhim Zahawi more like this
tabling member
4510
label Biography information for Helen Hayes more like this